Novartis settles with Henrietta Lacks' estate over use of her cells

Novartis has settled a lawsuit with the estate of Henrietta Lacks over the use of her cancer cells. The settlement resolves claims that Novartis unjustly profited from Lacks' cells, taken without her consent in 1951, which became crucial for medical advancements. Details of the agreement are not public. This is the second settlement for the Lacks estate, following a similar case with Thermo Fisher Scientific, as other lawsuits against pharmaceutical companies remain active.